NVST Stock — Envista Holdings Corporation

Envista Holdings Corporation (NVST)

Updated October 16, 2026.

NVST is a Stock. Total return is -18.1% over the past 7.1 years, 199.6 points behind SPY at 181.5%.

Envista Holdings Corporation develops, manufactures, and sells dental products globally, operating through two segments: Specialty Products & Technologies, which offers dental implants, orthodontic products, and imaging software under brands like Nobel Biocare and Ormco; and Equipment & Consumables, which provides dental equipment, supplies, and infection prevention products under brands like Kerr and Dexis. The company does not currently have an established distribution program. This business appeals to healthcare-focused equity investors seeking exposure to the dental industry.

NVST performance versus SPY

Price and return data through 2026-10-16.

Total return is -18.1% over the past 7.1 years, 199.6 points behind SPY at 181.5%. Over the past year its total return — price change plus distributions reinvested — is 16.1%. Its deepest 1-year drawdown was 26.0%.

NVST key facts

Asset type

Stock

Asset class

Equity

Inception date

09/18/2019

Distribution frequency

None

Last close

$22.90 (as of 2026-10-16)

Market cap

$3,678,145,536

Average volume

2324175.0

Beta

0.888

Payout ratio

0.0%

P/E ratio

39.48

Forward P/E

16.8067

EPS

$0.58

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

NVST risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 26.0%.

Who may consider NVST — and who may not

It is a weaker fit for investors who need monthly cash flow (NVST does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on NVST

• All tickers starting with N

Tagged: Healthcare.

Frequently asked questions